enGene Holdings Inc., through its subsidiary enGene, Inc., is a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. The company is headquartered in Saint-Laurent, Canada.
Click "Analyze" to generate stock analysis
ENGNW Price Trend and Signals
2025-08-28Somewhat Bearishprice_signal
Quarterly low detected.
2025-08-22Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-08-22Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-08-22Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-08-22Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-08-21Bullishprice_signal
Large price change detected: 21.54%.
2025-08-20Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-08-20Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-08-20Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-08-20Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.